Ignite Creation Date:
2024-05-06 @ 7:55 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02626507
Status:
UNKNOWN
Last Update Posted:
2022-02-09
First Post:
2015-12-07
Brief Title:
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ERHER2- Breast Cancer
Sponsor:
Hoffman Oncology
Organization:
Hoffman Oncology